TL1A primed dendritic cells activation exacerbated chronic murine colitis

Area of Science:

• Immunology
• Gastroenterology
• Cell Biology

Background:

• Tumor necrosis factor-like ligand 1A (TL1A) is known to activate adaptive immunity in inflammatory bowel disease (IBD).
• The precise role of TL1A in regulating intestinal dendritic cells (DCs) during colitis remains incompletely understood.

Purpose of the Study:

• To investigate the impact of TL1A on the activation of dendritic cells in a murine model of colitis.
• To elucidate the mechanisms by which TL1A influences DC function and contributes to intestinal inflammation.

Main Methods:

• Utilized myeloid TL1A-Transgenic C57BL/6 mice and wild-type (WT) mice subjected to dextran sulfate sodium (DSS)-induced colitis.
• Isolated bone marrow-derived dendritic cells (BMDCs) to assess phagocytosis and antigen presentation capabilities.
• Analyzed the expression of the nuclear factor-κB (NF-κB) pathway and chemokine receptors (CCRs) using real-time PCR and Western blot.

Main Results:

• TL1A transgenic mice exhibited exacerbated colitis with heightened T_H1/T_H17 responses.
• Intestinal DCs from TL1A transgenic mice showed increased expression of costimulatory molecules (CD80, CD86) and pro-inflammatory cytokines (IL-1β, TNF-α, IL-12/23 p40).
• TL1A enhanced DC phagocytosis, antigen processing/presentation, NF-κB pathway activation, and expression of CCR2, CCR5, CCR7, and CX3CR1.

Conclusions:

• TL1A significantly worsens DSS-induced chronic experimental colitis.
• TL1A likely exacerbates colitis through the activation and migration of dendritic cells.
• Increased secretion of pro-inflammatory cytokines driven by TL1A-activated DCs contributes to disease severity.